Florida to become first state to end all vaccine mandates, including in schools

Florida to become first state to end all vaccine mandates, including in schools


Ruth Jones, immunization nurse, holds a Pfizer-BioNTech COVID-19 vaccine (brand name: Comirnaty) at Borinquen Health Care Center in Miami, Florida, on May 29, 2025.

Joe Raedle | Getty Images

Florida plans to end all state vaccine mandates, including for children to attend schools, state Surgeon General Joseph Ladapo, a prominent immunization critic, announced Wednesday.

The move would make Florida the first-ever state in the U.S. to withdraw from the requirements that are credited with increasing vaccination rates in communities and preventing outbreaks of infectious diseases. The rollback could result in fewer school children getting immunized against deadly viruses such as polio and measles, and comes as Florida leads the Southeast in nonmedical vaccine exemptions among kindergartners.

“The Florida Department of Health, in partnership with the governor, is going to be working to end all vaccine mandates in Florida law, all of them. All of them. Every last one of them,” Ladapo said during a news conference, adding that the state has “maybe half a dozen” shots mandated in the state.

Florida Surgeon General Joseph Ladapo and Gov. Ron DeSantis at a news conference in West Palm Beach, Florida, on Jan. 6, 2022.

Joe Cavaretta | Tribune News Service | Getty Images

All states currently have vaccine requirements to attend public schools, though exceptions vary by state. Florida is among the states that already allow parents to object to vaccines on religious grounds.

Ladapo said vaccine mandates “drips with disdain and slavery,” even though they are intended to protect public health. Vaccines have saved the lives of more than 1.1 million children in the U.S. and saved Americans $540 billion in direct health-care costs over the past three decades, according to research from the Centers for Disease Control and Prevention released in August.

Ladapo has long stoked fears about vaccines, and his stances on shots and other measures have drawn criticism from the public health community. Last year, he called for a halt to using mRNA Covid-19 shots, citing false claims that the jabs could contaminate a person’s DNA.

The move comes as Health and Human Services Secretary Robert F. Kennedy Jr. moves to change vaccine policy in the U.S., gutting a key government immunization panel, canceling funding for mRNA shot development and dropping Covid shot recommendations for certain groups.

Don’t miss these insights from CNBC PRO



Source

Trump signs executive order reclassifying cannabis, opening door to broader weed access
Health

Trump signs executive order reclassifying cannabis, opening door to broader weed access

U.S. President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, D.C., U.S., Dec. 18, 2025. Evelyn Hockstein | Reuters President Donald Trump signed an executive order Thursday directing federal agencies to reclassify marijuana, loosening long-standing restrictions on the drug and marking the most consequential shift in […]

Read More
Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 
Health

Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound 

Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking the company’s injection Zepbound and Novo Nordisk’s rival shot Wegovy in a late-stage trial.  The company also said it has filed for Food and Drug Administration approval of the daily […]

Read More
Medical supply firm Medline set to debut after biggest IPO of 2025
Health

Medical supply firm Medline set to debut after biggest IPO of 2025

U.S. medical supplies giant Medline is set to debut on the Nasdaq on Wednesday after the biggest initial public offering of the year.  The private equity-owned company priced at $29 per share on Tuesday, raising $6.26 billion in an upsized offering that finishes off a strong year for new listings and bolsters optimism about the […]

Read More